Benefits of combining aripiprazole to clozapine: three case reports

Progress in Neuro-psychopharmacology & Biological Psychiatry
Fábio Lopes Rocha, Cláudia Hara

Abstract

A substantial number of patients treated with clozapine shows insufficient response. The author presents the results of adding aripiprazole in patients resistant to clozapine. Three cases of individuals with psychotic symptoms despite clozapine use and with significant side effects that were treated via this combination are presented. Response was evaluated by clinical assessment. Good clinical results were obtained in all three patients, with improvement of psychotic symptoms and of some of the side effects of clozapine. The findings from this case series suggest that adjunctive therapy with aripiprazole can be of benefit for treating clozapine resistant schizophrenic patients.

References

Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·R ShilohA Weizman
Feb 24, 2001·Journal of Psychopharmacology·D M Taylor, D Duncan-McConnell
Mar 14, 2003·The Journal of Clinical Psychiatry·Neil S Kaye
Apr 15, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Lefteris LykourasAndreas Rabavilas
May 4, 2004·The American Journal of Psychiatry·Marcus W AgelinkIsmail Ak
Jun 8, 2004·Human Psychopharmacology·M ZinkH Dressing
Jul 10, 2004·Psychiatrische Praxis·Mathias ZinkHarald Dressing
Sep 16, 2004·The Journal of Clinical Psychiatry·Sabina LimChandra Cooper
Dec 31, 2004·The American Journal of Psychiatry·Richard C JosiassenRita A Shaughnessy
Mar 23, 2005·Der Nervenarzt·M Zink, H Dressing
Mar 30, 2005·Clinical Neuropharmacology·Vladimir LernerChanoch Miodownik
Apr 13, 2005·Psychiatry and Clinical Neurosciences·Aygun ErtugrulKâzim M Yazici
Sep 28, 2005·CNS Drugs·Gary RemingtonChekkera Shammi
Feb 3, 2006·The New England Journal of Medicine·William G HonerUNKNOWN Clozapine and Risperidone Enhancement (CARE) Study Group

❮ Previous
Next ❯

Citations

Jun 16, 2012·Neuropsychiatric Disease and Treatment·Nilufar Mossaheb, Rainer M Kaufmann
Jul 22, 2010·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Alessandra BenedettiGiovanni Battista Cassano
May 9, 2012·Expert Opinion on Drug Safety·Juan A GallegoChristoph U Correll
Sep 22, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Bart Peters, Lieuwe de Haan
Apr 15, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Susanne Englisch, Mathias Zink
Jan 30, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Wiesław J CubałaJerzy Landowski
Jan 26, 2011·Schizophrenia Research·Maria Rosaria A MuscatelloRocco A Zoccali
Jun 10, 2015·Sleep Medicine Clinics·Kathleen L Benson
Mar 1, 2008·Journal of Psychopharmacology·G C-L Hung, Y-Y Chen
Apr 28, 2007·The Australian and New Zealand Journal of Psychiatry·Mathias ZinkAnna Kuwilsky
Dec 6, 2008·Journal of Psychiatric Practice·Anand K Pandurangi, Alican Dalkilic
Dec 4, 2008·Clinical Neuropharmacology·Ivan Lerma-CarrilloEnrique Baca-García
Aug 1, 2009·Clinical Neuropharmacology·Susanne EnglischMathias Zink
May 3, 2014·The Psychiatric Quarterly·Aurigena Antunes de AraújoCaroline Addison Carvalho Xavier de Medeiros
Nov 23, 2011·Clinical Neuropharmacology·Sandra SchönfelderMathias Zink
Mar 12, 2010·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Nilufar MossahebChristian Barnas
Jan 31, 2021·Medical Hypotheses·David D KimRic M Procyshyn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here